October 9, 2015
NATIONAL HARBOR, Md. — In this video, Gregg C. Fonarow, MD, professor of cardiology at UCLA and co-chair of the Heart Failure Society of America Annual Scientific Meeting scientific program, discusses several key sessions and presentations from this year’s conference.
The meeting program addressed all aspects of care for HF, from prevention to treatment of patients with advanced disease. He said that the plenary session, featuring a presentation by Robert Califf, MD, FDA deputy commissioner for medical products and tobacco, stressed the importance of generating high-level evidence and participation in clinical trials. Califf, recently nominated by President Barack Obama to serve as the next commissioner of the FDA, outlined the opportunities for patient management that follow from improved understanding of disease process, assembly of large data sets and advancement of clinical trials, Fonarow said.